Vedavaag Systems Regulatory Approval

Other Announcement

Vedavaag Systems Other Announcement

VEDAVAAG Systems Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, complying with regulatory disclosure requirements.

Capital Structure Change

Vedavaag Systems Capital Structure Change

Vedavaag Systems Limited will invest Rs. 0.75 Crore in its wholly-owned subsidiary, Vedavaag Financial Insurance Broking Services Private Limited, through a rights issue.

Value

₹0.75 Cr

Annual General Meeting

Vedavaag Systems Annual General Meeting

Vedavaag Systems Limited conducted its 28th Annual General Meeting on September 30, 2026. Shareholders adopted the FY2026 audited financial statements and re-appointed Mr. Ananth Jonnavittula as Director.

Business Update

Vedavaag Systems Business Update

Vedavaag Systems' board approved a capital investment in its wholly owned subsidiary, Vedavaag Financial Insurance Broking Services. Details will be disclosed upon receipt of regulatory approvals.

Annual General Meeting

Vedavaag Systems Annual General Meeting

Vedavaag Systems Limited announced its 28th Annual General Meeting is scheduled for September 30, 2026. The board approved the AGM notice, directors' report, and member register closure.

Board Meeting Date

Vedavaag Systems Board Meeting Date

Vedavaag Systems Limited has scheduled a board meeting for August 29, 2026. The meeting will address arrangements for the company's 28th Annual General Meeting.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.